Fast Mek1 Hit Identification with TRIC Technology Correlates Well with Other Biophysical Methods. (September 2021)
- Record Type:
- Journal Article
- Title:
- Fast Mek1 Hit Identification with TRIC Technology Correlates Well with Other Biophysical Methods. (September 2021)
- Main Title:
- Fast Mek1 Hit Identification with TRIC Technology Correlates Well with Other Biophysical Methods
- Authors:
- Jeridi, Semir
Rak, Alexey
Gupta, Amit
Soule, Pierre - Abstract:
- The variety and complexity of drug targets are expanding rapidly. At the same time, there is significant interest in exploring a larger chemical space to identify new candidates. Fragment-based screening (FBS) has emerged as a popular alternative to traditional high-throughput screening campaigns to identify such drug candidates. FBS identifies hit fragments that exhibit weak interactions with the target of interest, thereby enabling the rational design of small-molecule compounds from the identified hit fragments, which serve as building blocks. This strategy reduces the number of molecules to screen while also allowing the exploration of a greater chemical space. Here we use temperature-related intensity change (TRIC) technology to perform FBS against the target MAPK/ERK kinase-1 (Mek1). TRIC describes the change in fluorescence intensity of a fluorescently labeled molecule upon a change in temperature. This intensity variation is dependent on the physicochemical environment in the vicinity of the dye and strongly affected by binding events. Thus, the detection of binding events is independent of mass, making TRIC an ideal tool for FBS. Using only 150 pmol of labeled Mek1, the authors screened 193 fragments from a prescreened library in less than 1 h of measurement time, leading to 66 hits. Among those hits, they identified more than 80% of the published top hits found using orthogonal techniques. Furthermore, TRIC allowed the identification of fragments that were of poorThe variety and complexity of drug targets are expanding rapidly. At the same time, there is significant interest in exploring a larger chemical space to identify new candidates. Fragment-based screening (FBS) has emerged as a popular alternative to traditional high-throughput screening campaigns to identify such drug candidates. FBS identifies hit fragments that exhibit weak interactions with the target of interest, thereby enabling the rational design of small-molecule compounds from the identified hit fragments, which serve as building blocks. This strategy reduces the number of molecules to screen while also allowing the exploration of a greater chemical space. Here we use temperature-related intensity change (TRIC) technology to perform FBS against the target MAPK/ERK kinase-1 (Mek1). TRIC describes the change in fluorescence intensity of a fluorescently labeled molecule upon a change in temperature. This intensity variation is dependent on the physicochemical environment in the vicinity of the dye and strongly affected by binding events. Thus, the detection of binding events is independent of mass, making TRIC an ideal tool for FBS. Using only 150 pmol of labeled Mek1, the authors screened 193 fragments from a prescreened library in less than 1 h of measurement time, leading to 66 hits. Among those hits, they identified more than 80% of the published top hits found using orthogonal techniques. Furthermore, TRIC allowed the identification of fragments that were of poor solubility but could be mistaken as false-positive hits in other methods. … (more)
- Is Part Of:
- SLAS discovery. Volume 26:Number 8(2021)
- Journal:
- SLAS discovery
- Issue:
- Volume 26:Number 8(2021)
- Issue Display:
- Volume 26, Issue 8 (2021)
- Year:
- 2021
- Volume:
- 26
- Issue:
- 8
- Issue Sort Value:
- 2021-0026-0008-0000
- Page Start:
- 1014
- Page End:
- 1019
- Publication Date:
- 2021-09
- Subjects:
- TRIC -- Mek1 -- fragment-based screening -- drug discovery -- interactions
Drugs -- Analysis -- Periodicals
Drugs -- Testing -- Periodicals
Biomolecules -- Analysis -- Periodicals
Biomolecules -- Analysis
Drugs -- Analysis
Drugs -- Testing
Drug Evaluation, Preclinical
Molecular Biology -- methods
Periodicals
Periodicals
615.1 - Journal URLs:
- http://journals.sagepub.com/home/jbx ↗
https://www.sciencedirect.com/journal/slas-discovery/ ↗
http://www.sagepublications.com/ ↗
https://www.journals.elsevier.com/slas-discovery ↗ - DOI:
- 10.1177/24725552211026267 ↗
- Languages:
- English
- ISSNs:
- 2472-5552
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 16677.xml